The use of the C-13-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels

Author(s):
Opdam, F.L.; Dezentje, V.O.; Hartigh, J. den; Modak, A.S.; Vree, R.; Batman, E.; Smorenburg, C.H.; Nortier, J.W.R.; Gelderblom, H.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2013
Publication type
Article / Letter to editor
TamoxifenEndoxifenGenotypePhenotypeDextromethorphanBreath test
Date issued
2013-03-31
Language
English
Is part of
Cancer Chemotherapy and Pharmacology (2013), Vol. 71, no. 3, p. 593-601
hdl
1887/100098
doi
10.1007/s00280-012-2034-4